Fischer Medical Ventures Q2 FY25 earnings call: Revenue & Margins
Q2 FY25 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹40Cr
- +291.9% QoQ
- Net profit
- ₹0Cr
- Turned profitable QoQ
- Margin
- 1.26%
- +3.3 pp QoQ
Guidance rank: #10 of 13 in Healthcare Equipment & Supplies
See the sector's top 10 — free with your mobile number.
Based on Fischer Medical Ventures Ltd's Q2 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
The investor presentation reports the following for the quarter: - EBITDA: ₹36.3 crore, a 45.5% year-on-year increase.
From Fischer Medical Ventures Ltd's Q2 FY25 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
See what Fischer Medical Ventures Ltd said on revenue & sales performance — free account, 30 seconds.
Profitability & Margins
See what Fischer Medical Ventures Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Established manufacturing presence in India in 2022 at Andhra Pradesh Medtech Zone (AMTZ), described as the first and only accredited "Made in India" MRI facility (Page 3, 9).
- Strong sales pipeline of over 100 MRI units across India, MENA, and SEA regions (Page 9).
- Deployment of E-Health Access Points (eHAPs) and kiosks planned at 33,000 schools across India, with a full rollout expected over the next 3-5 years (Page 18).
2 more points from Fischer Medical Ventures Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Equipment & Supplies
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Fischer Medical Ventures Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The presentation mentions a "Strong Sales Pipeline of >100 Units of MRIs across India, MENA and SEA" (Page 9), indicating robust order inflow or pending orders.
- It refers to "Strong order books and expansion into new geographies and product lines" targeted for 2025 (Page 3).
Fischer Medical Ventures Ltd — Quarterly revenue & net profit
Fischer Medical Ventures Ltd Q2 FY25 results — key figures
| ₹ Cr | Q2 FY25 | Q1 FY25 | QoQ |
|---|---|---|---|
| Revenue | 40 | 10 | +291.9% |
| Operating profit (EBITDA) | 1 | -0 | — |
| Operating margin | 1.26% | -2.08% | +3.3 pp |
| Profit before tax | 0 | 0 | +200% |
| Net profit (PAT) | 0 | -0 | — |
| EPS (₹) | 0.01 | 0.00 | — |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹107 Cr, net profit ₹1 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Fischer Medical's management said in earlier quarters
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Equipment & Supplies
on management's own guidance
- Strong growth2
- Strong growth1
- Molbio DiagnostiGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Fischer Medical Ventures Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Fischer Medical Ventures Ltd Q2 FY25 results?
The investor presentation reports the following for the quarter: - EBITDA: ₹36.3 crore, a 45.5% year-on-year increase.
What is Fischer Medical Ventures Ltd share price analysis?
Fischer Medical Ventures Ltd currently shows a neutral. The stock trades at a P/E of 94.6 with a market cap of ₹2,316 Cr. Investors should review the full earnings analysis for detailed insights.
Is Fischer Medical Ventures Ltd planning capital expenditure?
Established manufacturing presence in India in 2022 at Andhra Pradesh Medtech Zone (AMTZ), described as the first and only accredited "Made in India" MRI facility (Page 3, 9).
Keep Fischer Medical Ventures Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
